openPR Logo
Press release

Chronic Kidney Disease Market Size Expected to Reach US$ 12,344.4 Million by 2033

12-11-2023 12:36 PM CET | Health & Medicine

Press release from: IMARC GROUP

Chronic Kidney Disease Market Size Expected to Reach US$

How big is CKD market?

The chronic kidney disease market size reached a value of US$ 4,934 Million in 2022 and expects to reach US$ 12,344.4 Million by 2033, exhibiting a growth rate (CAGR) of 8.7% during 2023-2033.

The chronic kidney disease market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the chronic kidney disease market.

Request for a Sample of this Report: https://www.imarcgroup.com/chronic-kidney-disease-market/requestsample

Chronic Kidney Disease Market Trends:

Chronic kidney disease (CKD) is a medical condition characterized by decreasing kidney function over a period of time. The chronic kidney disease market is undergoing significant expansion, propelled by various determinants. A primary catalyst is the growing elderly population, which is more vulnerable to ailments like diabetes and hypertension, the main causes of CKD. As the population's median age increases, chronic kidney disease prevalence escalates, leading to a heightened demand for diagnosis and care. The rise in conditions such as diabetes and hypertension boosts chronic kidney disease cases, even beyond the aging demographic. Several lifestyle determinants, including unbalanced diets and sedentary habits, amplify these diseases, thereby elevating chronic kidney disease risk.

Technological advancements in diagnostic procedures and treatments are facilitating CKD management. The introduction of wearables for instantaneous monitoring and AI-aided analytics aids timely detection, enhancing their market appeal. As economies flourish, more investments in healthcare ensure superior chronic kidney disease care, expanding the patient base who can access medications. Governments are actively tackling CKD. Measures centered on prompt diagnosis, raising public consciousness, and providing drug subsidies uplift market prospects. Major pharmaceutical entities' robust push into newer markets is heightening growth. By rendering chronic kidney disease therapies more approachable, they're broadening their consumer spectrum and forging fresh avenues. Amplified CKD cognizance, via educational endeavors and digital platforms, encourages individuals towards health vigilance, foreseeably bolstering the chronic kidney disease market in the upcoming years.

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the chronic kidney disease market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the chronic kidney disease market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current chronic kidney disease marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Competitive Landscape of Key Players::

The competitive landscape of the chronic kidney disease market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these Key Players:

AstraZeneca
Reata Pharmaceuticals
Boehringer Ingelheim/Eli Lilly and Company
Kibow Biotech
Allena Pharmaceuticals

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7413&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact Us:

IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Kidney Disease Market Size Expected to Reach US$ 12,344.4 Million by 2033 here

News-ID: 3322982 • Views:

More Releases from IMARC GROUP

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for CKD

Chronic Kidney Disease (CKD) Key Players, Share and Forecast Outlook
Chronic Kidney Disease (CKD) is a long-term medical condition characterized by a gradual decline in kidney function over time. CKD often leads to complications such as anemia, cardiovascular disease, and end-stage renal disease (ESRD), which necessitate dialysis or kidney transplant. With rising global cases of diabetes, hypertension, and aging populations, the demand for effective CKD management solutions has significantly grown. The CKD market, valued at USD 74.54 billion in 2024, is
Nephrology Drugs Market Booming Worldwide with Rising CKD Prevalence | AstraZene …
Nephrology Drugs Market Snapshot The Nephrology Drugs Market is projected to grow from USD 14.32 billion in 2024 to USD 21.01 billion by 2032, at a CAGR of 4.91% during the forecast period. Coherent Market Insights proudly presents its latest Nephrology Drugs Market Research Report, delivering a detailed examination of the U.S. Nephrology Drugs Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels,
Chronic Kidney Disease (CKD) Market CAGR: Growth, Share, Value, Size, and Analys …
Chronic Kidney Disease (CKD) Market Size And Forecast by 2030 Data Bridge Market Research analyses that the Global Chronic Kidney Disease (CKD) Market which was USD 13220 Billion in 2022 is expected to reach USD 18800.17 Million by 2030 and is expected to undergo a CAGR of 4.50% during the forecast period of 2022 to 2030 Explore Further Details about This Research Chronic Kidney Disease (CKD) Market Report https://www.databridgemarketresearch.com/reports/global-chronic-kidney-disease-ckd-market  **Segments** - **Type of CKD:**
Chronic Kidney Disease (CKD) Drugs Market- Boosting the Healthcare Industry Worl …
The global Chronic Kidney Disease (CKD) Drugs market is estimated to attain a valuation of USD 15.8 bn by the end of 2024, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3.6% during the forecast period, 2016 - 2024. The key objective of the TMR report is to offer a complete assessment of the global market
Semiconductor Air Cylinder Market: Players tapping Emerging Markets |Festo, SMC, …
Latest Study on Semiconductor Air Cylinder Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Semiconductor Air Cylinder market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, Growth Opportunities, Market Trend and Technologies, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends
Railway Valves Market global outlook and forecast 2021 -2027|Norgren ,CKD
The Global Railway Valves Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Railway Valves makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise spins around the most powerful